4//SEC Filing
Hagel Jillian Marie 4
Accession 0001493152-23-002449
CIK 0000890821other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:30 PM ET
Size
7.5 KB
Accession
0001493152-23-002449
Insider Transaction Report
Form 4
Hagel Jillian Marie
Chief Technology Officer
Transactions
- Award
Common Stock
2021-10-13+10,500→ 23,802 total - Award
Common Stock
2021-10-13+1,021→ 13,302 total
Footnotes (3)
- [F1]The reporting person received the RSUs as a one-time signing bonus upon the commencement of the reporting person's employment with the Company. 50% of the RSUs shall vest over 2 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest over 2 years in equal annual installments, if the Company's average VWAP exceeds 110% and 120% of $158.925, respectively.
- [F2]Includes 10,633 shares previously held through the Hagel 2020 Family Trust, which were distributed to the reporting person and are now owned directly.
- [F3]50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $119.00, $130.50 and $143.50, respectively.
Documents
Issuer
Enveric Biosciences, Inc.
CIK 0000890821
Entity typeother
Related Parties
1- filerCIK 0001883891
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:30 PM ET
- Size
- 7.5 KB